Primary non-Hodgkin's lymphoma of the breast: retrospective analysis of prognosis and patterns of failure in two Australian centers

Clinical Lymphoma & Myeloma
G RyanJ F Seymour

Abstract

The breast is an uncommon site of presentation for primary non-Hodgkin's lymphoma, with prognosis and patterns of relapse still not clearly defined. A retrospective analysis of 21 patients presenting to 2 Australian centers during a 20-year period is presented. All patients were women and had a median age of 62 years. Fifteen patients (71%) had localized disease (12 unilateral and 3 bilateral), and 6 (29%) had regional lymph-node involvement. Histology was predominantly intermediate grade, with diffuse large B-cell lymphoma (DLBL) in 16 cases (76%). The most common treatment program was partial mastectomy followed by chemotherapy and radiation therapy (n = 12). Complete response (CR) to treatment was exhibited in 19 patients (90%), 11 of whom subsequently experienced relapse. Including the 2 patients who failed to exhibit an initial CR, the median time to disease progression was 23.4 months (range, 0-143 months), with a 5-year disease-free survival rate of 38% (+/- 12%). The actuarial median survival of all patients was 3.8 years, with bilateral breast involvement at presentation the only significant prognostic factor. The contralateral breast was the site of initial relapse in 3 patients (17%), all of whom subsequently died of...Continue Reading

References

Feb 1, 1992·Cancer·R GiardiniF Rilke
Apr 23, 2002·Journal of Surgical Oncology·William W WongPaula J Schomberg
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E ZuccaUNKNOWN International Extranodal Lymphoma Study Group
Aug 15, 2003·Leukemia & Lymphoma·D GholamV Ribrag

❮ Previous
Next ❯

Citations

Apr 17, 2008·International Journal of Hematology·Hai-Yi GuoXi-Chun Hu
Apr 26, 2007·Annals of Surgery·William C JenningsThomas A Broughan
Nov 27, 2007·World Journal of Surgical Oncology·Shigeyuki NagataKenzo Wakasugi
Jul 3, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G MartinelliF Cavalli
May 29, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A AvivA Polliack
Jun 2, 2007·Cancer·Kristen GanjooSandra Horning
Jul 16, 2008·Radiologic Clinics of North America·Matthew J Matasar, Andrew D Zelenetz
Jun 24, 2014·Cancer Treatment Reviews·Chan Y CheahJohn F Seymour
Sep 20, 2006·Virchows Archiv : an International Journal of Pathology·Florian Rudolf FritzscheGlen Kristiansen
Jan 23, 2018·Breast Cancer Research and Treatment·Nafisha LalaniRachel B Jimenez
Oct 4, 2017·Southern Medical Journal·Alaa AlsadiPaolo Gattuso

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.